The combination of IDH1 mutations and MGMT methylation status predicts survival in glioblastoma better than either IDH1 or MGMT alone

RJ Molenaar, D Verbaan, S Lamba, C Zanon, JWM Jeuken, SHE Boots-Sprenger, P Wesseling, TJ Hulsebos, D Troost, AA van Tilborg, Sieger Leenstra, WP Vandertop, A Bardelli, CJF Van Noorden, FE Bleeker

Research output: Contribution to journalArticleAcademicpeer-review

147 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)1263-1273
Number of pages11
Issue number9
Publication statusPublished - 2014

Research programs

  • EMC MM-03-44-06
  • EMC OR-01-45-01

Cite this